This study investigated the effects of Tai Chi exercise on the levels of blood glucose,
insulin and insulin receptors of patients with type 2 diabetes. Twelve subjects aged 58-75
years old (66.5 ± 8.5 years) with type 2 diabetes participated in the study. They were trained
with the protocol of Tai Chi exercise for 8 weeks. Blood glucose, serum insulin, and insulin
receptor activity were measured before and after the 8-week intervention and immediately
after a single bout exercise of Tai Chi after the protocol. The results showed that by 8 weeks
of Tai Chi exercise, the blood glucose decreased (p < 0.05), while high- and low-affinity
insulin receptor numbers (r1, r2) and low-affinity insulin receptor binding capacity (R2)
increased. Serum insulin increased (p < 0.05) but was still within the normal range. After
the single bout Tai Chi exercise, blood glucose, high- and low-affinity insulin receptor numbers
(r1, r2), and their binding capacity (R1, R2) increased (p < 0.05), while serum insulin did
not change. The 8-week Tai Chi intervention therefore showed benefits on health status of
patients with type 2 diabetes.
Copyright / Drug Dosage
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.